Evidence map›Paper›PMID 39252018›Full record

Observational studyHarm reduction journal2024

ADHD: prevalence and effect on opioid use disorder treatment outcome in a French sample of patients receiving medication for opioid use disorder-the influence of impulsivity as a mediating factor.

Auxane Beslot, Marie Grall-Bronnec, Marianne Balem, Benoit Schreck, Edouard-Jules Laforgue, Caroline Victorri-Vigneau, Morgane Guillou-Landreat, Juliette Leboucher, OPAL-Group, Gaëlle Challet-Bouju and 1 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Harm reduction journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01847729 (A Multicenter Study Assessing the Prevalence of Co-addictions in Subjects Receiving Maintenance Treatment for Opiate Dependence. Determination of Clinical and Pharmacological Profil.), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01847729 completednot on this map

A Multicenter Study Assessing the Prevalence of Co-addictions in Subjects Receiving Maintenance Treatment for Opiate Dependence. Determination of Clinical and Pharmacological Profil.

TypeobservationalSponsorNantes University HospitalRan2013 to 2016Enrolled263ConditionsSubstance Use Disorder
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Stimulant Treatment Gap in ADHD Patients with Heroin Use Disorder: Clinical and Behavioural Consequences.International journal of environmental research and public health · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Auxane BeslotAddiction Medicine and Psychiatry Department, Nantes Université, CHU Nantes, Nantes, 44000, France.
Marie Grall-BronnecNantes Université, Univ Tours, CHU Nantes, INSERM, MethodS in Patients Centered Outcomes and HEalth ResEarch, SPHERE, Nantes, 44000, France. marie.bronnec@chu-nantes.fr.
Marianne BalemNantes Université, Univ Tours, CHU Nantes, INSERM, MethodS in Patients Centered Outcomes and HEalth ResEarch, SPHERE, Nantes, 44000, France.
Benoit SchreckNantes Université, Univ Tours, CHU Nantes, INSERM, MethodS in Patients Centered Outcomes and HEalth ResEarch, SPHERE, Nantes, 44000, France.
Edouard-Jules LaforgueNantes Université, Univ Tours, CHU Nantes, INSERM, MethodS in Patients Centered Outcomes and HEalth ResEarch, SPHERE, Nantes, 44000, France.
Caroline Victorri-VigneauNantes Université, Univ Tours, CHU Nantes, INSERM, MethodS in Patients Centered Outcomes and HEalth ResEarch, SPHERE, Nantes, 44000, France.
Morgane Guillou-LandreatAddiction Medicine Department, CHU Brest, Brest, France.
Juliette LeboucherAddiction Medicine and Psychiatry Department, Nantes Université, CHU Nantes, Nantes, 44000, France.
OPAL-Group
Gaëlle Challet-BoujuAddiction Medicine and Psychiatry Department, Nantes Université, CHU Nantes, Nantes, 44000, France.
Clémence CabelguenAddiction Medicine and Psychiatry Department, Nantes Université, CHU Nantes, Nantes, 44000, France.

Funding

French Inter-ministerial Mission for Combating Drugs and Addictive Behaviours (MILDECA) and Université Paris 13 PREVDROG
6 · The paper itself

Abstract

backgroundOpioid use disorder (OUD) poses a global health challenge, and despite medications for opioid use disorder (MOUD) and psychosocial interventions, relapse remains a significant concern. Comorbid psychiatric disorders, including attention deficit hyperactivity disorder (ADHD), are one of the major factors associated with poor OUD treatment outcome. We aimed to estimate the frequency of probable ADHD (in childhood and in adulthood) in patients with OUD; to assess the factors associated with this comorbidity; and to explore the factors that mediate the relationship between ADHD and OUD treatment outcome.

methodsWe conducted an observational study using a sample of 229 patients aged 18 years and older who were diagnosed with OUD and had received MOUD for at least six months. Participants were assessed through a structured interview and self-report questionnaires. Multivariate logistic regressions and a mediation analysis were performed.

resultsAlmost half of the participants reported probable ADHD in childhood, and ADHD persisted into adulthood among two-thirds of the patients. The factors associated with poor OUD treatment outcome included earlier onset of OUD, lower education, and greater impulsivity. There was no direct effect of probable ADHD in childhood on OUD treatment outcome, but there was an indirect effect through negative urgency, the tendency to respond impulsively to negatively connoted emotional experiences.

conclusionsThe findings suggest that ADHD symptoms, particularly impulsivity, may contribute to vulnerability in opioid use and play a crucial role in treatment outcomes for this population.

trial registrationClinicalTrials identifier NCT01847729.

Indexed as

Attention Deficit Disorder with HyperactivityImpulsive BehaviorOpiate Substitution TreatmentOpioid-Related DisordersAdolescentAdultAnalgesics, OpioidComorbidityFemaleFranceHumansMaleMiddle AgedPrevalenceTreatment OutcomeYoung AdultAnalgesics, OpioidAttention deficit hyperactivity disorderImpulsivityMediationMedication for opioid use disorderOpioid use disorderOutcome

Identifiers

PMID39252018
PMCPMC11382469

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.